Our Leadership
In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the R&D ecosystem.
In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining, and creating processes to make the drug development environment efficient, safe, and innovative.
View TransCelerate’s leadership here.
Board Of Directors
-
Janice Chang
CEO, TransCelerate BioPharma Inc.
-
Badhri Srinivasan
Chair of the Board, TransCelerate BioPharma; Head, Global Development Operations, Novartis
-
Robert Metcalf
Vice Chair of the Board, TransCelerate BioPharma; Group Vice President, CDDA, China & Japan Medical, Eli Lilly and Company
-
Eliav Barr
Senior Vice President, Global Clinical Development, Chief Medical Officer, MSD
-
Dietmar Berger
Chief Medical Officer, Global Head of Development, Sanofi
-
Christopher Corsico
SVP, Head of Development, GSK
-
Rob Goodwin
Senior Vice President and Head of Clinical Development & Operations, Pfizer
-
Lykke Hinsch Gylvin
Chief Medical Officer, Head of Global Medicine, Boehringer Ingelheim
-
Narimon Honarpour
Senior Vice President, Global Development, Amgen
-
Christoph Koenen
Head of Global Development and Clinical Operations, Pharmaceuticals Research & Development, Bayer
-
Maria Koutsopoulou
Senior Vice President, Head of Global Development Operations, Merck KGaA
-
Bari Kowal
Senior Vice President, Development Operations and Portfolio Management, Regeneron
-
Fabio Lievano
Vice President of Patient Safety, Scientific Collaborations, and New Business Development, AbbVie
-
Iris Loew-Friedrich
EVP and CMO, UCB
-
Cristian Massacesi
Chief Medical Officer and Chief Development Officer Oncology, AstraZeneca
-
Kate Owen
Head, Global Development Janssen Research & Development, LLC
-
Merdad Parsey
Chief Medical Officer, Gilead Sciences
-
Michelle Rohrer
SVP, Global Head of Pharma Regulatory and Policy, Roche
-
Takuko Sawada
Director, Vice President of the Board, Shionogi & Co., Ltd.
-
Thomas Senderovitz
Senior Vice President, Data Science, Novo Nordisk
-
Mokash Sharma
Head of Clinical Development, BMS
-
Tadaaki Taniguchi
Chief Medical Officer, Astellas
Leadership
-
Allison Cuff Shimooka
COO, TransCelerate BioPharma Inc.
-
Andy Lee
Corporate Treasurer, TransCelerate
SVP, Head of Global Clinical Trial Operations, Merck -
Emily Bachman
Oversight Committee Chair, TransCelerate
Executive Director of Data Science Business & Operations Management, Astellas -
Sven Kohler
Pharmacovigilance Steering Committee Chair, TransCelerate
EU-QPPV and Head of Regional Patient Safety & Pharmacovigilance, Boehringer Ingelheim -
Jennifer Burgess
Vice President, Global Communications & Engagement, TransCelerate BioPharma Inc.
-
Rob DiCicco
Vice President, Portfolio Management, TransCelerate BioPharma, Inc.
-
Cara Rinaldi
Vice President, Portfolio Management, TransCelerate BioPharma Inc.
-
Jeneen Donadeo
Executive Director, Portfolio Management,
TransCelerate BioPharma Inc. -
Tony Garges
Executive Director, Finance & Administration
TransCelerate BioPharma Inc.